CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial-Reference-Cited by-同舟云学术

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

Published:2008-02 Issue:2 Volume:9 Page:132-138
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Hess Viviane,Glimelius Bengt,Grawe Philipp,Dietrich Daniel,Bodoky György,Ruhstaller Thomas,Bajetta Emilio,Saletti Piercarlo,Figer Arie,Scheithauer Werner,Herrmann Richard

Publisher

Elsevier BV

Subject

Oncology

Reference21 articles.

1. Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer;Boeck;Oncology,2006

2. Specific antigen in serum of patients with colon carcinoma;Koprowski;Science,1981

3. Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?;Gogas;Br J Cancer,1998

4. Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer;Halm;Br J Cancer,2000

5. CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer;Ishii;Hepatogastroenterology,1997

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic implication of extra-pancreatic organ invasion in resectable pancreas ductal adenocarcinoma in the pancreas tail;European Journal of Radiology;2024-12

2. Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated with systemic chemotherapy;Annals of Medicine;2024-09-02

3. Angling for improvement: The search for novel biomarkers in periampullary adenocarcinoma;The American Journal of Surgery;2024-07

4. Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study);Cancer;2024-04-29

5. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17